Manufacturer of Controlled Substances Registration: Cody Laboratories, Inc., 22634 [2016-08843]
Download as PDF
<![CDATA[
22634
Federal Register / Vol. 81, No. 74 / Monday, April 18, 2016 / Notices
(individual member), Sydney,
AUSTRALIA; Douglas McGee
(individual member), Columbus, OH;
and Nick Ryan (individual member),
London, UNITED KINGDOM, have been
added as parties to this venture.
Also, Ad-ID, New York, NY; CNN/
Turner Broadcasting System, Atlanta,
GA; Masstech Group, Inc., Markham,
Ontario, CANADA; Video Stream
Networks (VSN), Barcelona, SPAIN; and
SDVI Corporation, Menlo Park, CA,
have withdrawn as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and Advanced
Media Workflow Association, Inc.
intends to file additional written
notifications disclosing all changes in
membership.
On March 28, 2000, Advanced Media
Workflow Association, Inc. filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on June 29, 2000 (65 FR 40127).
The last notification was filed with
the Department on December 23, 2015.
A notice was published in the Federal
Register pursuant to section 6(b) of the
Act on January 22, 2016 (81 FR 3823).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2016–08804 Filed 4–15–16; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Manufacturer of Controlled
Substances Registration: Cody
Laboratories, Inc.
ACTION:
Notice of registration.
Cody Laboratories, Inc.
applied to be registered as a
manufacturer of certain basic classes of
controlled substances. The Drug
Enforcement Administration (DEA)
grants Cody Laboratories, Inc.
registration as a manufacturer of those
controlled substances.
SUPPLEMENTARY INFORMATION: By notice
dated December 4, 2015, and published
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
in the Federal Register on December 10,
2015, 80 FR 76709, Cody Laboratories,
Inc., 601 Yellowstone Avenue, Cody,
Wyoming 82414 applied to be registered
as a manufacturer of certain basic
classes of controlled substances. No
comments or objections were submitted
for this notice.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of Cody Laboratories,
Inc. to manufacture the basic classes of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above-named company is
granted registration as a bulk
manufacturer of the following basic
classes of controlled substances:
Controlled substance
Dihydromorphine (9145) ...............
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
4-Anilino-N-phenethyl-4-piperidine
(ANPP) (8333).
Phenylacetone (8501) ..................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Morphine (9300) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Alfentanil (9737) ...........................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Tapentadol (9780) ........................
Fentanyl (9801) ............................
Schedule
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for sale to its customers.
Dated: April 11, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–08843 Filed 4–15–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Research Triangle
Institute
ACTION:
Notice of registration.
Research Triangle Institute
applied to be registered as an importer
of certain basic classes of controlled
substances. The Drug Enforcement
Administration (DEA) grants Research
Triangle Institute registration as an
importer of those controlled substances.
SUMMARY:
By notice
dated July 29, 2015, and published in
the Federal Register on August 4, 2015,
80 FR 46330, Research Triangle
Institute, Kenneth S. Rehder, Hermann
Building East Institute Drive, Room 106,
Research Triangle Park, North Carolina
27709–2194 applied to be registered as
an importer of certain basic classes of
controlled substances. No comments or
objections were submitted for this
notice.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of
Research Triangle Institute to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated the company’s
maintenance of effective controls
against diversion by inspecting and
testing the company’s physical security
systems, verifying the company’s
compliance with state and local laws,
and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of the following basic classes
of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Schedule
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)1-pentyl-1H-indazole-3-carboxamide) (7023) ...................................................
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (7031) .........................
AM–2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) (7201) .............................................................................................................
VerDate Sep<11>2014
17:54 Apr 15, 2016
Jkt 238001
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
E:\FR\FM\18APN1.SGM
18APN1
I
I
I
]]>Agencies
[Federal Register Volume 81, Number 74 (Monday, April 18, 2016)]
[Notices]
[Page 22634]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-08843]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Manufacturer of Controlled Substances Registration: Cody
Laboratories, Inc.
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Cody Laboratories, Inc. applied to be registered as a
manufacturer of certain basic classes of controlled substances. The
Drug Enforcement Administration (DEA) grants Cody Laboratories, Inc.
registration as a manufacturer of those controlled substances.
SUPPLEMENTARY INFORMATION: By notice dated December 4, 2015, and
published in the Federal Register on December 10, 2015, 80 FR 76709,
Cody Laboratories, Inc., 601 Yellowstone Avenue, Cody, Wyoming 82414
applied to be registered as a manufacturer of certain basic classes of
controlled substances. No comments or objections were submitted for
this notice.
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of Cody Laboratories, Inc. to
manufacture the basic classes of controlled substances is consistent
with the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated the company's maintenance of effective
controls against diversion by inspecting and testing the company's
physical security systems, verifying the company's compliance with
state and local laws, and reviewing the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the above-named company is granted registration as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Dihydromorphine (9145)..................... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Methylphenidate (1724)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
4-Anilino-N-phenethyl-4-piperidine (ANPP) II
(8333).
Phenylacetone (8501)....................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Diphenoxylate (9170)....................... II
Ecgonine (9180)............................ II
Hydrocodone (9193)......................... II
Meperidine (9230).......................... II
Methadone (9250)........................... II
Methadone intermediate (9254).............. II
Morphine (9300)............................ II
Thebaine (9333)............................ II
Oxymorphone (9652)......................... II
Alfentanil (9737).......................... II
Remifentanil (9739)........................ II
Sufentanil (9740).......................... II
Tapentadol (9780).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for sale to its customers.
Dated: April 11, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-08843 Filed 4-15-16; 8:45 am]
BILLING CODE 4410-09-P
